Abstract:Telomeresplay a vital role in DNA repair activities and protecting chromosomes from degradation[1]. Telomeres are shortened during each cell division because of the end replication problem. After several cell division, telomeres are shortened to a critical length (< 3 kb), and eventually lead to overall genomic instability and triggering the DNA damage response[2-3], which is related to the cancerization of numerous cancers. The commonly used method to estimate telomere length isterminal restriction fragment (TRF) basedon southern blot, which requires thousands of cells and provides only a crude estimate of the average telomere length of all cells analyzed. However, it is believed that the frequency of critically short telomeres, rather than the mean telomere length, is a crucial factor for telomere dysfunction. Therefore, analysis of telomere length at the single-chromosome level is necessary to determine the frequency of critically short telomeres. Here, we describe the development of a high-throughput method for telomere length analysis at the single-chromosome level by using a laboratory-built high-sensitivity flow cytometer (HSFCM)[4] combined with targeted fluorescent peptide nucleic acid (PNA) probes. The unambiguous detection of the telomere signalsfrom a single chromosome was achieved via HSFCM analysis. The fluorescence intensity of single chromosome was converted to the probe number by a calibration curve, and was further transformed to the base pair number of the telomere. Five representative cell lines were analyzed to compare their telomere length and the ratio of critically short telomeres at the single-chromosome level. The potential of using frequency of short telomere for disease treatment monitoring is examined by analyzing the telomere length in lymphocyte of leukemia patients. The abundance of short telomeres was compared between healthy donors and patients with chronic myeloid leukemia (CML) to see whether it can be used to predict the efficacy of therapeutics. Moreover, the quantity of short telomeres was compared among patients with acute leukemia, patients in different phases of CML and healthy donors to see whether it can be used as a marker for disease progression prediction in CML. Reference [1] Blackburn E. H., Epel E. S., Lin J., Science,2015, 350, 1193-1198. [2]Collado M., Blasco M. A., Serrano M., Cell, 2007, 130, 223-233. [3] Deng Y., Chan S. S., Chang S., Nat. Rev. Cancer, 2008, 8, 450-458. [4] Yang LL, Zhu SB, Hang W, Wu LN, Yan XM, Anal. Chem., 2009, 81, 2555-2563. Figure 1 Disclosures No relevant conflicts of interest to declare.

Telomere Dysfunction in Chronic Lymphocytic Leukemia

The complexities of T cell dysfunction in Chronic Lymphocytic Leukemia

Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes

Role of the ESCRT Complexes in Telomere Biology

Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes

Loss of Telomere Protection: Consequences and Opportunities

This is a Title in Title Case: Prediction of CML Evolution by Telomere Length Analysis at the Single-Chromosome Level

Telomere Length Dynamics and the Evolution of Cancer Genome Architecture

Telomere length and telomerase expression activity in mononuclear cells of patients with chronic lymphocytic leukemia]

Shelterin complex in telomere protection: recent insights and pathological significance

Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia

Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond

Molecular map of chronic lymphocytic leukemia and its impact on outcome

Inherited Telomere Biology Disorders: Pathophysiology, Clinical Presentation, Diagnostics, and Treatment

Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescuing and cancer mutations

Different phenotypes with different endings—Telomere biology disorders and cancer predisposition with long telomeres

Telomere Dysfunction in Peripheral Lymphocytes As a Potential Predisposition Factor for Renal Cancer

Transcriptional Outcome of Telomere Signalling

Recent advances in understanding telomere diseases

Shelterin complex and associated factors at human telomeres